Contribution of ADAMTS13‐independent VWF regulation in sickle cell disease

Abstract

BackgroundVon Willebrand factor (VWF) is elevated in sickle cell disease (SCD) and contributes to vaso‐occlusion through its thrombogenic properties. VWF is regulated by ADAMTS13, a plasma protease that cleaves VWF into less bioactive multimers. Independent investigations have shown VWF to be elevated in SCD, whereas measurements of ADAMTS13 have been variable. ObjectivesWe assessed ADAMTS13 activity using multiple activity assays and measured levels of alternative VWF‐cleaving proteases in SCD. Methods/ PatientsPlasma samples were collected from adult patients with SCD (n = 20) at a single institution when presenting for routine red cell exchange transfusion therapy. ADAMTS13 activity was measured by FRETS‐VWF73, Technozym ADAMTS‐13 Activity ELISA kit and a full‐length VWF digestion reaction. Alternative VWF‐cleaving proteases were identified by ELISA. A cell culture model was used to study the impact of SCD stimuli on endothelial ADAMTS13 and alternative VWF‐cleaving proteases. ResultsADAMTS13 activity was found to be moderately deficient across the SCD cohort as assessed by activity assays using a VWF A2 domain peptide substrate. However, SCD plasma showed preserved ability to digest full‐length VWF, suggesting assay‐discrepant results. Neutrophil and endothelial‐derived proteases were found to be elevated in SCD plasma. Matrix metalloproteinase 9 specifically showed preferential cleavage of full‐length VWF. Upregulation of alternative VWF‐cleaving proteases occurred in endothelial cells exposed to SCD stimuli such as heme and hypoxia. ConclusionsThis is the first demonstration of accessory plasma enzymes contributing to the regulation of VWF in a specific disease state and may have implications for assessing the VWF/ADAMTS13 axis in other settings.